Archives of Men's Health

Hanna NH, Einhorn LH. Testicular cancer — discoveries and updates. New England Journal of Medicine. 2014; 371(21):2005-2016. doi:10.1056/nejmra1407550

Albers P, Albrecht W, Algaba F, et al. Guidelines on testicular cancer: 2015 update. European Urology. 2015;68(6):1054-1068. doi:10.1016/j.eururo.2015.07.044

Ryan, S. J., & Hoyt, M. A. Adult self-image and well-being after testicular cancer: The role of agency and meaning. Psychology & Health. 2018; 33(8): 1049–1061.

Rossen, P. B., Pedersen, A. F., Zachariae, R., & von der Maase, H. Health-related quality of life in long-term survivors of testicular cancer. Journal of Clinical Oncology. 2009; 27(35): 5993–5999.

Vasiľková, L. Vplyv liečby na kognitívne funkcie a kvalitu života u pacientov s karcinomom semenníkov. Klinická onkologie. 2016; 29(4).

Eberhard, J., Ståhl, O., Cohn-Cedermark, G., Cavallin-Ståhl, E., Giwercman, Y., Rastkhani, H., Rylander, L., Eberhard-Gran, M., Kvist, U., & Giwercman, A. Emotional disorders in testicular cancer survivors in relation to hypogonadism, androgen receptor polymorphism and treatment modality. Journal of Affective Disorders. 2010; 122(3): 260–266. https://doi.org/10.1016/j.jad.2009.06.035

Haugnes, H. S., Bosl, G. J., Boer, H., Gietema, J. A., Brydøy, M., Oldenburg, J., ... & Fosså, S. D. Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol. 2012; 30(30): 3752–63.

Caruso, R., Nanni, M. G., Riba, M. B., Sabato, S., & Grassi, L. The burden of psychosocial morbidity related to cancer: Patient and family issues. International Review of Psychiatry. 2017; 29(5): 389–402. https://doi.org/10.1080/09540261.2017.1288090

Lee, B. K., Glass, T. A., McAtee, M. J., Wand, G. S., Bandeen-Roche, K., Bolla, K. I., & Schwartz, B. S. Associations of Salivary Cortisol with Cognitive Function in the Baltimore Memory Study. Archives of General Psychiatry. 2007; 64(7):810. https://doi.org/10.1001/archpsyc.64.7.810

Jahnukainen, K., Ehmcke, J., Hou, M., & Schlatt, S. Testicular function and fertility preservation in male cancer patients. Best Practice & Research. Clinical Endocrinology & Metabolism. 2011; 25(2):87–302.

Menning, S., de Ruiter, M. B., Kieffer, J. M., van Rentergem, J. A., Veltman, D. J., Fruijtier, A., ... & Schagen, S. B. Cognitive impairment in a subset of breast cancer patients after systemic therapy—results from a longitudinal study. Journal of Pain and Symptom Management. 2016; 52(4):560–569.

Jim, H. S., Phillips, K. M., Chait, S., Faul, L. A., Popa, M. A., Lee, Y. H., ... & Small, B. J. Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy. Journal of Clinical Oncology. 2012; 30(29): 3578–3587.

Amidi, A., Agerbæk, M., Wu, L. M., Pedersen, A. D., Mehlsen, M., Clausen, C. R., ... & Zachariae, R. Changes in cognitive functions and cerebral grey matter and their associations with inflammatory markers, endocrine markers, and APOE genotypes in testicular cancer patients undergoing treatment. Brain Imaging and Behavior. 2017a; 11: 769–783.

Ståhl, O., Eberhard, J., Jepson, K., Spano, M., Cwikiel, M., Cavallin-Ståhl, E., & Giwercman, A. Sperm DNA integrity in testicular cancer patients. Human Reproduction. 2006; 21(12):3199–3205.

Raphael, M., Wei, X., Karim, S., Robinson, A., Bedard, P., & Booth, C. Neurotoxicity Among Survivors of Testicular Cancer: A Population-based Study. Clinical Oncology. 2019; 31(9):653–658. https://doi.org/10.1016/j.clon.2019.04.008

Ahles, T. A., & Saykin, A. Cognitive effects of standard-dose chemotherapy in patients with cancer. Cancer Investigation. 2001;19(8):812–820.

Chovanec, M., Zaid, M. A., Hanna, N., El-Kouri, N., Einhorn, L. H., & Albany, C. Long-term toxicity of cisplatin in germ-cell tumor survivors. Annals of Oncology. 2017; 28(11):2670–2679.

Fung, C., Dinh, P., Ardeshir-Rouhani-Fard, S., Schaffer, K., Fossa, S. D., & Travis, L. B. (2018). Toxicities associated with cisplatin-based chemotherapy and radiotherapy in long-term testicular cancer survivors. Advances in Urology, 2018.

Lauritsen, J., Bandak, M., Kreiberg, M., Skøtt, J. W., Wagner, T., Rosenvilde, J. J., Dysager, L., Agerbæk, M., & Daugaard, G. Long-term neurotoxicity and quality of life in testicular cancer survivors—a nationwide cohort study. Journal of Cancer Survivorship. 2020; 15(4):509–517. https://doi.org/10.1007/s11764-020-00944-1

Mercadante, S., Gebbia, V., Marrazzo, A., & Filosto, S. Anaemia in cancer: pathophysiology and treatment. Cancer Treatment Reviews. 2000; 26(4):303–311.

Hare, G. M., Hum, K. M., Kim, S. Y., Barr, A., Baker, A. J., & Mazer, C. D. Increased cerebral tissue oxygen tension after extensive hemodilution with a hemoglobin-based oxygen carrier. Anesthesia & Analgesia. 2004; 99(2):528–535.

Bray, V. J., Dhillon, H. M., & Vardy, J. L. Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment. Journal of Cancer Survivorship. 2018; 12(4):537–559.

Amidi, A., Wu, L. M., Agerbæk, M., Larsen, P. L., Pedersen, A. D., Mehlsen, M., ... & Zachariae, R. Cognitive impairment and potential biological and psychological correlates of neuropsychological performance in recently orchiectomized testicular cancer patients. Psycho‐Oncology. 2015a; 24(9):1174–1180.

Whitford, H. S., Kalinowski, P., Schembri, A., Grimison, P., Stockler, M., Martin, A., ... & Australian and New Zealand Urogenital and Prostate Cancer Trials Group. The impact of chemotherapy on cognitive function: A multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer. 2020; 28:3081–3091.

Pedersen, A. D., Rossen, P., Mehlsen, M. Y., Pedersen, C. G., Zachariae, R., & Von Der Maase, H. Long-term cognitive function following chemotherapy in patients with testicular cancer. Journal of the International Neuropsychological Society. 2009; 15(2):296–301.

Wefel, J. S., Vidrine, D. J., Marani, S. K., Swartz, R. J., Veramonti, T. L., Meyers, C. A., ... & Gritz, E. R. A prospective study of cognitive function in men with non‐seminomatous germ cell tumors. Psycho‐Oncology. 2014; 23(6):626–633.

Amidi, A., Wu, L. M., Pedersen, A. D., Mehlsen, M., Pedersen, C. G., Rossen, P., ... & Zachariae, R. Cognitive impairment in testicular cancer survivors 2 to 7 years after treatment. Supportive Care in Cancer. 2015b; 23:2973–2979.

Stouten‐Kemperman, M. M., de Ruiter, M. B., Caan, M. W., Boogerd, W., Kerst, M. J., Reneman, L., & Schagen, S. B. Lower cognitive performance and white matter changes in testicular cancer survivors 10 years after chemotherapy. Human Brain Mapping. 2015; 36(11):4638–4647.

Stelwagen, J., Meuleman, A. T., Lubberts, S., Steursma, G., Kruyt, L. M., Donkerbroek, J. W., ... & Gietema, J. A. Cognitive Impairment in Long-Term Survivors of Testicular Cancer More Than 20 Years after Treatment. Cancers. 2021;13(22):5675.

Wefel, J. S., Vidrine, D. J., Veramonti, T. L., Meyers, C. A., Marani, S. K., Hoekstra, H. J., ... & Gritz, E. R. Cognitive impairment in men with testicular cancer prior to adjuvant therapy. Cancer.2011; 117(1):190-196.

Buskbjerg, C. R., Zachariae, R., Agerbæk, M., Gravholt, C. H., Haldbo-Classen, L., Hosseini, S. H., & Amidi, A. Cognitive impairment and associations with structural brain networks, endocrine status, and risk genotypes in newly orchiectomized testicular cancer patients. Brain Imaging and Behavior. 2022; 1–12.

Buskbjerg, C. R., Amidi, A., Agerbaek, M., Gravholt, C. H., Hosseini, S. H., & Zachariae, R. Cognitive changes and brain connectomes, endocrine status, and risk genotypes in testicular cancer patients–A prospective controlled study. Cancer Medicine. 2021; 10(18):6249–6260.

Schagen, S. B., Boogerd, W., Muller, M. J., Ten Bokkel Huinink, W., Moonen, L., Meinhardt, W., & Van Dam, F. S. Cognitive complaints and cognitive impairment following BEP chemotherapy in patients with testicular cancer. Acta Oncologica. 2008; 47(1):63–70.

Amidi, A., Hosseini, S. H., Leemans, A., Kesler, S. R., Agerbæk, M., Wu, L. M., & Zachariae, R. Changes in brain structural networks and cognitive functions in testicular cancer patients receiving cisplatin-based chemotherapy. JNCI: Journal of the National Cancer Institute. 2017b; 109(12):djx085.

Skaali, T., Fosså, S. D., Andersson, S., Cvancarova, M., Langberg, C. W., Lehne, G., & Dahl, A. A. A prospective study of neuropsychological functioning in testicular cancer patients. Annals of Oncology. 2011a; 22(5):1062–1070.

Gritz, E. R., Wellisch, D. K., & Landsverk, J. A. Psychosocial sequelae in long-term survivors of testicular cancer. Journal of Psychosocial Oncology. 1988; 6(3-4): 41–63.

Skaali, T., Fosså, S. D., & Dahl, A. A. A prospective study of cognitive complaints in patients with testicular cancer. Clinical Genitourinary Cancer. 2011b; 9(1): 6–13.

Skoogh, J., Steineck, G., Stierner, U., Cavallin-Ståhl, E., Wilderäng, U., Wallin, A., ... & Swenoteca. Testicular-cancer survivors experience compromised language following chemotherapy: findings in a Swedish population-based study 3–26 years after treatment. Acta Oncologica. 2011;51(2):185–197.

Oechsle, K., Hartmann, M., Mehnert, A., Oing, C., Bokemeyer, C., & Vehling, S. Symptom burden in long-term germ cell tumor survivors. Supportive Care in Cancer. 2016;24: 2243–2250.

Chovanec, M., Vasilkova, L., Setteyova, L., Obertova, J., Palacka, P., Rejlekova, K., ... & Mego, M. Long‐term cognitive functioning in testicular germ‐cell tumor survivors. The Oncologist. 2018;23(5):617–623.

Manhaes, M. F. M., Okuma, G. Y., Pedras, R. N., de Domenico, E. B. L., & Bergerot, C. D. Biopsychosocial needs of survivors of testicular cancer and evidence of validation of a brief scale. Estudos de Psicologia (Campinas). 2019;36.

Nowe, E., Friedrich, M., Leuteritz, K., Sender, A., Stöbel-Richter, Y., Schulte, T., ... & Geue, K. Cancer-related fatigue and associated factors in young adult cancer patients. Journal of Adolescent and Young Adult Oncology. 2019;8(3):297–303.

Skaali, T., Fosså, S. D., Andersson, S., Cvancarova, M., Langberg, C. W., Lehne, G., & Dahl, A. A. Self-reported cognitive problems in testicular cancer patients: relation to neuropsychological performance, fatigue, and psychological distress. Journal of Psychosomatic Research. 2011c;70(5):403–410.

Skaali, T., Fosså, S. D., Bremnes, R., Dahl, O., Haaland, C. F., Hauge, E. R., ... & Dahl, A. A. Fear of recurrence in long‐term testicular cancer survivors. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer. 2009;18(6):580–588.

Bower, J. E. Cancer-related fatigue—mechanisms, risk factors, and treatments. Nature Reviews Clinical Oncology.2014;11(10):597–609. https://doi.org/10.1038/nrclinonc.2014.127

Stouten-Kemperman, M. M., de Ruiter, M. B., Boogerd, W., Kerst, J. M., Kirschbaum, C., Reneman, L., & Schagen, S. B. Brain hyperconnectivity> 10 years after cisplatin-based chemotherapy for testicular cancer. Brain Connectivity. 2018; 8(7):398–406.

Skaali, T., Fosså, S. D., Andersson, S., Langberg, C. W., Lehne, G., & Dahl, A. A. Is psychological distress in men recently diagnosed with testicular cancer associated with their neuropsychological test performance? Psycho‐Oncology. 2011d;20(4):369–377.

McDougall Jr, G. J., Oliver, J. S., & Scogin, F. Memory and cancer: a review of the literature. Archives of psychiatric nursing. 2014; 28(3):180-186.

Vannorsdall, T. D. Cognitive changes related to cancer therapy. Medical Clinics. 2017; 101(6):1115-1134.

Ahles, T. A., Saykin, A. J., McDonald, B. C., Li, Y., Furstenberg, C. T., Hanscom, B. S., Mulrooney, T. J., Schwartz, G. N., & Kaufman, P. A. Longitudinal Assessment of Cognitive Changes Associated with Adjuvant Treatment for Breast Cancer: Impact of Age and Cognitive Reserve. Journal of Clinical Oncology. 2010;28(29):4434–4440. https://doi.org/10.1200/jco.2009.27.0827

Schagen, S. B., Muller, M. J., Boogerd, W., Mellenbergh, G. J., & Van Dam, F. S. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients. Journal of the National Cancer Institute. 2006;98(23):1742–1745.

Kreukels, B. P., Schagen, S. B., Ridderinkhof, K. R., Boogerd, W., Hamburger, H. L., Muller, M. J., & van Dam, F. S. Effects of high-dose and conventional-dose adjuvant chemotherapy on long-term cognitive sequelae in patients with breast cancer: An electrophysiologic study. Clinical Breast Cancer. 2006;7(1):67–78.

de Ruiter, M. B., Reneman, L., Boogerd, W., Veltman, D. J., Caan, M., Douaud, G., Lavini, C., Linn, S. C., Boven, E., van Dam, F. S., & Schagen, S. B. Late effects of high-dose adjuvant chemotherapy on white and gray matter in breast cancer survivors: Converging results from multimodal magnetic resonance imaging. Human Brain Mapping. 2012;33(12):2971–2983. https://doi.org/10.1002/hbm.21422

Oh, P. J. Predictors of cognitive decline in people with cancer undergoing chemotherapy. European Journal of Oncology Nursing. 2017; 27:53–59.

Argyriou, A. A., Assimakopoulos, K., Iconomou, G., Giannakopoulou, F., & Kalofonos, H. P. Either called “chemobrain” or “chemofog,” the long-term chemotherapy-induced cognitive decline in cancer survivors is real. Journal of Pain and Symptom Management. 2011;41(1):126–139.

Hardy, S. J., Krull, K. R., Wefel, J. S., & Janelsins, M. Cognitive changes in cancer survivors. American Society of Clinical Oncology Educational Book. 2018; 38:795–806.

Hutchinson, A. D., Hosking, J. R., Kichenadasse, G., Mattiske, J. K., & Wilson, C. Objective and subjective cognitive impairment following chemotherapy for cancer: a systematic review. Cancer Treatment Reviews. 2012;38(7):926–934.

Zachariae, R., & Mehlsen, M. Y. Is chemotherapy associated with cognitive impairment? Nature Reviews Urology.2011; 8(4):182–183.

Doyle, R., Craft, P., Turner, M., & Paterson, C. Identifying the unmet supportive care needs of individuals affected by testicular cancer: a systematic review. Journal of Cancer Survivorship. 2022;1–25.

Fardell, J. E., Vardy, J., Johnston, I. N., & Winocur, G. Chemotherapy and cognitive impairment: treatment options. Clinical Pharmacology & Therapeutics. 2011;90(3): 366–376.

Schiepers, O. J., Wichers, M. C., & Maes, M. Cytokines and major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2005;29(2):201–217.

Hermelink, K., Untch, M., Lux, M. P., Kreienberg, R., Beck, T., Bauerfeind, I., & Münzel, K. Cognitive function during neoadjuvant chemotherapy for breast cancer. Cancer. 2007;109(9):1905–1913. https://doi.org/10.1002/cncr.22610

Deprez, S., Kesler, S. R., Saykin, A. J., Silverman, D. H. S., de Ruiter, M. B., & McDonald, B. C. International Cognition and Cancer Task Force Recommendations for Neuroimaging Methods in the Study of Cognitive Impairment in Non-CNS Cancer Patients. JNCI: Journal of the National Cancer Institute. 2018;110(3):223–231. https://doi.org/10.1093/jnci/djx285

Vitali, M., Ripamonti, C. I., Roila, F., Proto, C., Signorelli, D., Imbimbo, M., ... & Russo, G. L. Cognitive impairment and chemotherapy: a brief overview. Critical Reviews in Oncology/Hematology. 2017;118:7–14.

Tannock, I. F., Ahles, T. A., Ganz, P. A., & Van Dam, F. S. Cognitive impairment associated with chemotherapy for cancer: Report of a workshop. Journal of Clinical Oncology. 2004; 22(11):2233–2239.

Mitchell, T., & Turton, P. ‘Chemobrain’: concentration and memory effects in people receiving chemotherapy–a descriptive phenomenological study. European Journal of Cancer Care. 2011;20(4):539–548.

Schepisi, G., De Padova, S., De Lisi, D., Casadei, C., Meggiolaro, E., Ruffilli, F., ... & De Giorgi, U. Psychosocial issues in long-term survivors of testicular cancer. Frontiers in Endocrinology. 2019; 10:113.

Ng T, Sreemanee Raaj Dorajoo, Yin Ting Cheung, et al. Distinct and heterogeneous trajectories of self-perceived cognitive impairment among Asian breast cancer survivors. Psycho-Oncology. 2018;27(4):1185-1192. doi:https://doi.org/10.1002/pon.4635

Ahles TA, Saykin AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nature Reviews Cancer. 2007;7(3):192-201. doi:https://doi.org/10.1038/nrc2073

Whitford HS, Kalinowski P, Schembri A, et al. The impact of chemotherapy on cognitive function: a multicentre prospective cohort study in testicular cancer. Supportive Care in Cancer. 2019;28(7):3081-3091. doi:https://doi.org/10.1007/s00520-019-05095-3

Rogers LR. Neurologic Complications of Radiation. CONTINUUM: Lifelong Learning in Neurology. 2012;18:343-354. doi:https://doi.org/10.1212/01.con. 0000413662.35174.a8

Dropcho EJ. Neurotoxicity of Radiation Therapy. Neurologic Clinics. 2010;28(1):217-234. doi:https://doi.org/10.1016/j.ncl.2009.09.008

Barnett M, McDonnell G, DeRosa A, et al. Psychosocial outcomes and interventions among cancer survivors diagnosed during adolescence and young adulthood (AYA): a systematic review. Journal of Cancer Survivorship. 2016;10(5):814-831. doi:https://doi.org/10.1007/s11764-016-0527-6

Chovanec M, Galikova D, Vasilkova L, et al. Chemotherapy-induced peripheral neuropathy (CIPN) as a predictor of decreased quality of life and cognitive impairment in testicular germ cell tumor survivors. Journal of Clinical Oncology. 2020;38(15_suppl):e17063-e17063. doi:https://doi.org/10.1200/jco.2020.38.15_suppl.e17063

Skoogh J, Steineck G, Cavallin-Ståhl E, et al. Feelings of loss and uneasiness or shame after removal of a testicle by orchidectomy: a population-based long-term follow-up of testicular cancer survivors. International Journal of Andrology. 2010;34(2):183-192. doi:https://doi.org/10.1111/j.1365-2605.2010.01073.x

Wortel RC, Alemayehu WG, Incrocci L. Orchiectomy and Radiotherapy for Stage I–II Testicular Seminoma: A Prospective Evaluation of Short‐Term Effects on Body Image and Sexual Function. The Journal of Sexual Medicine. 2015;12(1):210-218. doi:https://doi.org/10.1111/jsm.12739

Rossen P, Pedersen AF, Zachariae R, von der Maase H. Sexuality and body image in long-term survivors of testicular cancer. European Journal of Cancer. 2012;48(4):571-578. doi:https://doi.org/10.1016/j.ejca.2011.11.029

Tedeschi RG, Calhoun LG. Posttraumatic growth: Conceptual foundations and empirical evidence. Psychological Inquiry. 2004;15(1):1-18. doi:https://doi.org/10.1207/s15327965pli1501_01